# US 2025/0146064 A1 · Methods of sequencing nucleic acids and error correction of sequence reads

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0146064 A1
- Document ID: US20250146064A1
- Status: Published application
- Kind: A1
- Application number: 18/929,516
- Filed: 2024-10-28
- Published: 2025-05-08
- Earliest claimed: 2018-03-22
- Assignees: Inivata Ltd.
- Applicants: Inivata Ltd.
- Inventors: Samuel WOODHOUSE; Tim FORSHEW; Stefanie Viola LENSING
- Web page: https://patentgrep.com/patent/US20250146064A1

## CPC

- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6858: Allele-specific amplification
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Described herein, among other things, is a method of sequencing nucleic acids of interest (NAOIs). In some embodiments the method may comprise: providing a sample comprising NAOIs; attaching oligonucleotides to the NAOIs to provide labelled NAOIs, wherein the oligonucleotides comprise a PCR cycle counter generator sequence comprising at least one universal nucleotide base; amplifying the labelled NAOIs using PCR to provide an amplified library of NAOIs each containing a PCR cycle counter sequence; sequencing the amplified library of NAOIs to provide a set of sequence reads, wherein each sequence read comprises a NAOI-originating component and a PCR cycle counter component; and distinguishing true variants in NAOI sequences from false variants in NAOI sequences.

## Claims

### Claim 1

A method of sequencing nucleic acids of interest (NAOIs), comprising:
a. providing a sample comprising parental NAOIs;
b. attaching oligonucleotides to the parental NAOIs to provide labelled parental NAOIs, wherein the oligonucleotides comprise a PCR cycle counter generator sequence comprising at least one universal nucleotide base;
c. amplifying the labelled parental NAOIs using PCR, wherein each cycle of the PCR amplification generates a new PCR cycle counter every time a labelled parental NAOI is copied by a polymerase, to provide an amplified library of daughter NAOIs each containing a PCR cycle counter sequence;
d. sequencing the amplified library of daughter NAOIs to provide a set of sequence reads, wherein each sequence read comprises a NAOI-originating component and a PCR cycle counter component; and
e. distinguishing true variants in parental NAOI sequences from false variants in parental NAOI sequences by counting the number of different PCR counter sequences.

### Claim 2 (depends on 1)

The method of claim 1, wherein the oligonucleotide is a double stranded oligonucleotide comprising a first and a second strand, the first strand comprising a sequencing adaptor, a PCR cycle counter generator sequence and a 3′ ligation moiety, and the second strand comprising a sequencing adaptor, a region complementary to the PCR cycle counter generator sequence, and a 5′ ligation moiety.

### Claim 3 (depends on 2)

The method of claim 2, wherein amplification by PCR uses primers directed towards the oligonucleotide attached in step (b).

### Claim 4 (depends on 1)

The method of claim 1, further comprising comparing the NAOI-originating portion of the sequence reads with a reference sequence or a database of reference sequences.

### Claim 5 (depends on 4)

The method of claim 4, wherein the reference sequence is a reference genome, reference gene, or a reference genomic region, or a database of reference genomes, reference genes, or reference genomic regions.

### Claim 6 (depends on 4)

The method of claim 4, wherein the variants in parental NAOI sequence are variants compared to the reference sequence or an entry in the database of reference sequences.

### Claim 7 (depends on 6)

The method of claim 6, wherein the larger the number of different PCR counter sequences associated with each different NAOI-originating component or portion thereof, the higher probability there is of the variant being a true variant.

### Claim 8 (depends on 1)

The method of claim 1, wherein distinguishing true variants in parental NAOI sequence from false variants in parental NAOI sequence comprises quantifying the relative amount of each different PCR cycle counter for a given NAOI sequence.

### Claim 9 (depends on 1)

The method of claim 1, wherein distinguishing true variants in parental NAOI sequence from false variants in parental NAOI sequence comprises comparing the number of PCR cycle counter sequences associated with each different NAOI-originating portion with the number of PCR cycles performed in step (c).

### Claim 10 (depends on 9)

The method of claim 9, wherein when the number of different PCR counter sequences associated with a given NAOI-originating portion is greater than the number of PCR cycles performed, this is indicative of the presence of a true variant.

### Claim 11 (depends on 1)

The method of claim 1, further comprising tagging the parental NAOIs prior to amplification with a molecular barcode.

### Claim 12 (depends on 11)

The method of claim 11, wherein the oligonucleotides comprise the molecular barcode.

### Claim 13 (depends on 11)

The method of any claim 11, wherein distinguishing true variants in a parental NAOI sequence from false variants in a parental NAOI sequence comprises:
a) grouping the sequence reads according to the sequence of the molecular barcode and optionally the sequence of the NAOI-originating component to group together all sequence reads arising from the same parental NAOI molecule;
b) counting the number of different PCR cycle counters associated each different sequence of NAOI-originating component in the sequence reads.

### Claim 14 (depends on 13)

The method of claim 13, wherein the NAOI-originating portion sequence having the highest number of different PCR cycle counters associated with it is identified as the true parental NAOI sequence.

### Claim 15 (depends on 11)

The method of claim 11, further comprising:
a) grouping the sequence reads according to the sequence of the molecular barcode and optionally the sequence of the NAOI-originating component to group together all sequence reads arising from the same parental NAOI;
b) aligning the sequence reads according to the sequence of the NAOI-originating portion; and
c) determining a consensus sequence for the parental NAOI, wherein the consensus sequence represents the sequence with the highest probability of being the true sequence of the parental NAOI, comprising identifying any nucleotide in the NAOI-originating portion of a sequence read for which more than one type of nucleotide is reported in a group of aligned sequence reads and counting the number of different PCR cycle counters associated with each reported nucleotide.

### Claim 16 (depends on 13)

The method of claim 13, further comprising selecting the nucleotide that is associated with the largest number of different PCR cycle counters for the consensus sequence.

### Claim 17

A double-stranded oligonucleotide comprising a first and a second strand, the first strand comprising a PCR cycle counter generator sequence comprising one or more universal bases and a 3′ ligation moiety, and the second strand comprising a region complementary to the PCR cycle counter generator sequence and a 5′ ligation moiety.

### Claim at position 18

18-33. (canceled)

### Claim 34 (depends on 17)

A pool of oligonucleotide comprising at least 1000 oligonucleotides of claim 17.

### Claim 35 (depends on 1)

A method of diagnosing a disease, comprising:
a. providing a sample from a patient, said sample comprising one or more NAOIs; and
b. sequencing one or more NAOIs according to claim 1;
c. diagnosing a disease according to the sequence of the NAOIs.

### Claim at position 21

36-39. (canceled)

### Claim 40 (depends on 34)

A kit of parts, comprising the pool of oligonucleotides of claim 34 and instructions for use.
